Gloucester Pharmaceuticals, Inc. Announces Presentations Of Depsipeptide (FK228) Data At The 47th Annual Meeting Of The American Society of Hematology

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dec. 1, 2005--Gloucester Pharmaceuticals, Inc.: Data on ongoing cutaneous T-cell lymphoma and multiple myeloma studies to be presented Gloucester Pharmaceuticals, Inc., a privately held cancer therapeutics development company, announced today that three abstracts relating to the Company's lead product candidate, depsipeptide, have been accepted for presentation at the 47th Annual Meeting of the American Society of Hematology (ASH), to be held in Atlanta, GA from December 9 - 13, 2005. Two additional abstracts relating to depsipeptide have been accepted for publication only. Full text of all abstracts can now be viewed on the ASH website at www.hematology.org.